The tripping point: The potential role of psychedelic-assisted therapy in the response to the opioid crisis
International Journal of Drug Policy February 10, 2019 Elena Argento, Kenneth W. Tupper, M. Eugenia Socias 17 citations
The contamination of the drug supply with illicitly manufactured fentanyl and related analogs in North America has caused the most severe drug-overdose crisis in history. Available pharmacotherapy for opioid use disorder has had limited success, and evidence highlights the need for interventions targeting social-structural drivers. Re-emerging clinical research suggests psychedelic-assisted therapy has potential as an alternative treatment for refractory substance use disorders and related comorbidities. The authors support advancing research on psychedelic-assisted therapy within a multifaceted response to the opioid crisis.